Bromide

Bromide

SCHEMBL5680650

CC1NCCc2ccc(O)cc21.[Br-].[H+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOA P21397 8/20 0.60
DRD2 P14416 4/20 0.60
HSD17B10 Q99714 2/20 0.60
TSHR P16473 2/20 0.60
KDM4E B2RXH2 1/20 0.60
CYP2C9 P11712 1/20 0.60
DRD3 P35462 1/20 0.60
HIF1A Q16665 1/20 0.60
DRD4 P21917 1/20 0.60
CYP2D6 P10635 1/20 0.51
ALDH1A1 P00352 1/20 0.51
DRD1 P21728 2/20 0.46
SLC6A9 P48067 1/20 0.45
KDM1A O60341 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5682329 0.97 MAOA (0.64) MAOADRD2HSD17B10TSHRKDM4E
SCHEMBL30199335 0.97 MAOA (0.64) MAOADRD2HSD17B10TSHRKDM4E
SCHEMBL21470621 0.97 MAOA (0.64) MAOADRD2HSD17B10TSHRKDM4E
Bromide SCHEMBL5680654 0.95 MAOA (0.65) MAOADRD2HSD17B10TSHRKDM4E
SCHEMBL21959060 0.83 MAOA (0.64) MAOADRD2HSD17B10TSHRKDM4E
Bromide SCHEMBL21858250 0.81 MAOA (0.65) MAOADRD2HSD17B10TSHRKDM4E
Bromide SCHEMBL30645357 0.81 MAOA (0.65) MAOADRD2HSD17B10TSHRKDM4E
Bromide SCHEMBL31505378 0.81 MAOA (0.65) MAOADRD2HSD17B10TSHRKDM4E
SCHEMBL19512604 0.77 MAOA (0.56) MAOADRD2HSD17B10TSHRKDM4E
SCHEMBL1011743 0.77 MAOA (0.56) MAOADRD2HSD17B10TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084154-B2 2-(aminomethyl) arylamide analgesics PHARMACOPEIA DRUG DISCLOVERY, INC. (US) 2006-08-01 US disclosed
US-20040167119-A1 2-(aminomethyl) arylamide analgesics PHARMACOPEIA, INC (US) 2004-08-26 US disclosed
WO-2004071445-A2 2-(AMINOMETHYL)ARYLAMIDE ANALGESICS PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167119-A1 2-(aminomethyl) arylamide analgesics OPRL1, OPRM1, OPRK1 MAOA 115/4885DRD2 808/4885HSD17B10 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.